Mechanistically, O-GlcNAcylation increases the expression of HCF-1, and O-GlcNAcylated HCF-1 then upregulates ChREBP, thus promoting DNL in hepatic steatosis [85]. The gene discussed is HCFC1; the disease is fatty liver disease.